Leaders in Learning: Publications of Faculty & Staff


 Clinical Neurological Sciences: 1998-1999

 

ANDERSON, C.

Rice, G.P.A., C. Anderson, N.J. Risch, and G.C. Ebers. 1999. Male Homosexuality: Absence of linkage to microsatellite markers at Xq28. Science 284 (April): 665-667.

 

BARNETT, H.J.M.

Ferguson, G.G., M. Eliasziw, H.W.K. Barr, C.P. Clagett, R.W. Barnes, M.C. Wallace, D.W. Taylor, R.B. Haynes, J.W. Finan, V.C. Hachinski, H.J.M. Barnett, and The North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. 1999. The North American Symptomatic Carotid Endarterectomy Trial. Surgical results in 1415 patients. Stroke 30 (9): 1751-1763.

Taylor, D.W., H.J.M. Barnett, R.B. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, et al, and The ASA and Carotid Endarterectomy Trial Collaborators. 1999. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid. The Lancet 353: 2179-2184.

 

BARR, H.W.K.

Ferguson, G.G., M. Eliasziw, H.W.K. Barr, C.P. Clagett, R.W. Barnes, M.C. Wallace, D.W. Taylor, R.B. Haynes, J.W. Finan, V.C. Hachinski, H.J.M. Barnett, and The North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. 1999. The North American Symptomatic Carotid Endarterectomy Trial. Surgical results in 1415 patients. Stroke 30 (9): 1751-1763.

 

BASKERVILLE, J.

Cottrell, D.A., M. Kremenchutzky, Rice G.P.A., W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122 (April): 641-647.

Cottrell D.A., M. Kremenchutzky, G.P.A. Rice, W.J. Koopman, W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122 (April): 625-639.

 

BLUME, W.T.

Blume, W.T. 1998. Hemispheric Epilepsy. Brain 121: 1937-1949.

Blume, W.T. 1999. Normal EEG in Children. Education Program Syllabus of the American Academy of Neurology 51st Annual Meeting. Toronto, Ontario: 17 April 1999-24 April 1999. American Academy of Neurology. 7FC.005-1 - .

Blume, W.T. 1998. The Real Morbidity of Epilepsy. Syllabus for Toronto Neurology Update. 28 November 1998.

Blume, W.T., and M. Kaibara. 1998. Atlas of Pediatric Electroencephalography. 2nd ed. Philadelphia, New York: Lippincott-Raven Publishers. xvii, 391 pp. Includes bibliographical references and index.

Blume, W.T., J. Ravindran, and N. Lowry. 1998. Late lateralising EEG features of scalp-recorded temporal lobe seizures. Journal of Clinical Neurophysiology 15 (6): 514-.

Blume, W.T., and F.W. Sharbrough. 1999. EEG Monitoring During Carotid Endarterectomy and Open Heart Surgery (Chapter 45). Electroencephalography, Basic Principles, Clinical Applications and Related Fields. 4th ed. E. Niedermeyer, and F. Lopes da Silva. Baltimore, Maryland: Williams & Wilkins. 797-808.

Blume, W.T., and S. Wiebe. 1999. Occipital Lobe Epilepsies. Advances in Neurology. P.D. Williamson, A.M. Siegel, D.W. Roberts, W.M. Thadani, and M.S. Gazzaniga. Philadelphia: Lippincott-Raven.

Gross, D.W., S. Wiebe, and W.T. Blume. 1999. The periodicity of lateralized epileptiform discharges. Clinical Neurophysiology 110: 1516-1520.

Parrent, A.G., and W.T. Blume. 1999. Stereotactic amygdalohippocampotomy for the treatment of mesial temporal lobe epilepsy. Epilepsia 40 (10): 1408-1416.

 

BOLTON, C.F.

Young, G.B., and C.F. Bolton. 1999. Good Fare Lessens Care (Editorial). Critical Care Medicine 27: 11.

 

CHAN, R.K.

Chan, R.K., and V.C. Hachinski. 1998. Vascular Dementia. Textbook of Neurology. B. Fisher, and J. Bougousslavsky. Butterworth Publishing.

 

COMPSTON, D.A.S.

Compston, D.A.S., G.C. Ebers, H. Lassmann, I. McDonald, B. Matthews, and H. Wekerle. 1998. McAlpine's Multiple Sclerosis. 3rd ed. London, England: Churchill Livingston, Division of Harcourt Brace. xiii, 592 pp. Includes bibliographical references and index.

 

COTTRELL D.A.

Cottrell, D.A., M. Kremenchutzky, Rice G.P.A., W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122 (April): 641-647.

Cottrell D.A., M. Kremenchutzky, G.P.A. Rice, W.J. Koopman, W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122 (April): 625-639.

 

DAVIDSON, W.

Kertesz, A., W. Davidson, and D.G. Munoz. 1999. Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: The Pick complex. Dementia and Geriatric Cognitive Disorders 10: 46-49.

 

DEL MAESTRO, R.F.

Clarson, C.L., and R.F. Del Maestro. 1999. Growth failure after treatment of pediatric brain tumors. Pediatrics 103: 1-6.

Del Maestro, R.F. 1998. Angiogenesis. The Gliomas. M. Berger, and C. Wilson. Philadelphia, Penn.: W.B. Saunders. 87-106.

Del Maestro, R.F. 1998. Leonardo da Vinci: the search for the soul. Journal of Neurosurgery 89: 874-887.

Sedlakova, R., R.R. Shivers, and R.F. Del Maestro. 1999. Ultrastructure of the Blood-Brain Barrier in the Rabbit. Journal of Submicroscopic Cytology and Pathology 31: 149-161.

Tamaki, M., W. McDonald, and R.F. Del Maestro. 1998. The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells. Journal of Neurooncology 39: 205-216.

 

DYMENT, D.A.

Ebers, G.C., and D.A. Dyment. 1999. Genetic and Environmental Factors. Sclerosi Multipla, Stato Dell'Arte. C. Fieschi, G. Comi, and C. Pozzilli. Milan, Italy: Mosby Italia. 3-8.

 

EBERS, G.C.

Compston, D.A.S., G.C. Ebers, H. Lassmann, I. McDonald, B. Matthews, and H. Wekerle. 1998. McAlpine's Multiple Sclerosis. 3rd ed. London, England: Churchill Livingston, Division of Harcourt Brace. xiii, 592 pp. Includes bibliographical references and index.

Cottrell, D.A., M. Kremenchutzky, Rice G.P.A., W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122 (April): 641-647.

Cottrell D.A., M. Kremenchutzky, G.P.A. Rice, W.J. Koopman, W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122 (April): 625-639.

Ebers, G.C., and D.A. Dyment. 1999. Genetic and Environmental Factors. Sclerosi Multipla, Stato Dell'Arte. C. Fieschi, G. Comi, and C. Pozzilli. Milan, Italy: Mosby Italia. 3-8.

Ebers, G.C., G.P.A. Rice, and The PRISMS Study Group. 1998. Randomised, double-blind, placebo-controlled study of interferon ß-1a in relapsing-remitting multiple sclerosis. Lancet 352 (9139): 1498-1504.

Goodin, D.S., G.C. Ebers, K.P. Johnson, M. Rodriguez, W.A. Sibley, and J.S. Wolinsky. 1999. The relationship of MS to physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52 (June): 1737-1745.

Noseworthy, J.H., P. O'Brien, B.J. Erickson, D.H. Lee, D. Sneve, G.C. Ebers, G.P.A. Rice, A. Auty, W. Hader, A. Kirk, P. Duquette, J. Carter, G. Francis, L. Metz, and E. Shuster. 1998. The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis. Neurology 51: 1342-1352.

Rice, G.P.A., C. Anderson, N.J. Risch, and G.C. Ebers. 1999. Male Homosexuality: Absence of linkage to microsatellite markers at Xq28. Science 284 (April): 665-667.

Rice, G.P.A., and G.C. Ebers. 1998. Interferons in the treatment of multiple sclerosis: do they prevent the progression of the disease? Archives of Neurology 55 (Dec.): 1578-1580.

Rice, G.P.A., G.C. Ebers, F.D. Lublin, and R.L. Knobler. 1999. Ibuprofen treatment versus gradual introduction of interferon ß-1b in patients with MS. Neurology 52 (June): 1893-1895.

Rice, G.P.A., B. Paszner, J. Oger, J. Lesaux, D. Paty, and G.C. Ebers. 1999. The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon ß-1b. Neurology 52 (6): 1277-1279.

Sadovnick, A.D., N.J. Risch, G.C. Ebers, and The Canadian Collaborative Study Group. 1998. Canadian Collaborative Project on Genetic Susceptibility of MS - Phase 2: Rationale and method. Canadian Journal of Neurological Sciences 25 (August): 216-221.

 

FERGUSON, G.G.

Ferguson, G.G., M. Eliasziw, H.W.K. Barr, C.P. Clagett, R.W. Barnes, M.C. Wallace, D.W. Taylor, R.B. Haynes, J.W. Finan, V.C. Hachinski, H.J.M. Barnett, and The North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. 1999. The North American Symptomatic Carotid Endarterectomy Trial. Surgical results in 1415 patients. Stroke 30 (9): 1751-1763.

Taylor, D.W., H.J.M. Barnett, R.B. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, et al, and The ASA and Carotid Endarterectomy Trial Collaborators. 1999. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid. The Lancet 353: 2179-2184.

 

GIRVIN, J.P.

Herrick, I.A., R.A. Craen, A.W. Gelb, R.S. McLachlan, J.P. Girvin, A.G. Parrent, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: electrocorticographic and epileptogenic effects. Anesthesia and Analgesia 84: 1280-1284.

Herrick, I.A., R.A. Craen, A.W. Gelb, L.A. Miller, C.S. Kubu, J.P. Girvin, A.G. Parrent, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: patient-controlled adminstration versus neurolept analgesia. Anesthesia and Analgesia 84: 1285-1291.

 

GOODIN, D.S.

Goodin, D.S., G.C. Ebers, K.P. Johnson, M. Rodriguez, W.A. Sibley, and J.S. Wolinsky. 1999. The relationship of MS to physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52 (June): 1737-1745.

 

HACHINSKI, V.C.

Chan, R.K., and V.C. Hachinski. 1998. Vascular Dementia. Textbook of Neurology. B. Fisher, and J. Bougousslavsky. Butterworth Publishing.

Ferguson, G.G., M. Eliasziw, H.W.K. Barr, C.P. Clagett, R.W. Barnes, M.C. Wallace, D.W. Taylor, R.B. Haynes, J.W. Finan, V.C. Hachinski, H.J.M. Barnett, and The North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. 1999. The North American Symptomatic Carotid Endarterectomy Trial. Surgical results in 1415 patients. Stroke 30 (9): 1751-1763.

Hachinski, V.C. 1999. Brain Attack. The Clinical Handbook. Guelph, Ontario: Meducom International.

Hachinski, V.C. 1998. Una epidemia de disfuncion cognitiva de origen vascular? Fronteras en la enfermedad cerebrovascular. J.T. Robertson, and T.S. Novak. American Heart Association.

Tamayo, A., and V.C. Hachinski. 1999. Acute Intervention in Stroke. Third European American Conference of Neurology. A.A. Gimeno, and P. Herman. Madrid: Fundacion Ramon Areces. 183-205.

Taylor, D.W., H.J.M. Barnett, R.B. Haynes, G.G. Ferguson, D.L. Sackett, K.E. Thorpe, D. Simard, F.L. Silver, V.C. Hachinski, et al, and The ASA and Carotid Endarterectomy Trial Collaborators. 1999. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid. The Lancet 353: 2179-2184.

 

HADER, W.

Cottrell, D.A., M. Kremenchutzky, Rice G.P.A., W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122 (April): 641-647.

Cottrell D.A., M. Kremenchutzky, G.P.A. Rice, W.J. Koopman, W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122 (April): 625-639.

Noseworthy, J.H., P. O'Brien, B.J. Erickson, D.H. Lee, D. Sneve, G.C. Ebers, G.P.A. Rice, A. Auty, W. Hader, A. Kirk, P. Duquette, J. Carter, G. Francis, L. Metz, and E. Shuster. 1998. The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis. Neurology 51: 1342-1352.

 

HAHN, A.F.

Hadden, R.D.M., D.R. Cornblath, R.A.C. Hughes, J. Zielasek, H.-P. Hartung, K.V. Toyka, Swan A.V., A.F. Hahn, and The Plasma Exchange Sandoglobulin Guillain-Barre Syndrome Trial Group. 1998. Electrophysiological Classification of Guillain-Barré Syndrome: Clinical Associations and Outcome. Annals of Neurology 44: 780-788.

Hahn, A.F. 1998. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Neurology 51 (Suppl 5): S16-S21.

 

HUDSON, A.J.

Delorey, R., H.A. Leeper, and A.J. Hudson. 1999. Measures of velopharygeal functioning in subgruops of individuals with amyotrophic lateral sclerosis. Journal of Medical Speech-Language Pathology 27 (2): 19-31.

Hudson, A.J. 1998. The fibromyalgia problem. Journal of Rheumatology 25: 1025-1030.

 

JOG, M.S.

Connolly, C., J.B. Burns, R. Grupen, and M.S. Jog. 1998. A dynamical-systems model for Parkinson's disease. Society for Neuroscience (Nov.).

 

JOHNSON, K.P.

Goodin, D.S., G.C. Ebers, K.P. Johnson, M. Rodriguez, W.A. Sibley, and J.S. Wolinsky. 1999. The relationship of MS to physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52 (June): 1737-1745.

 

KERTESZ, A.

Kertesz, A. 1999. American Academy of Neurology Antidementia Drug Review. ID Weekly Highlights 19 (May): 20-24.

Kertesz, A. 1999. The effects of Donepezil in Alzheimer's disease - results from a multinational trial. Clinical Review 10: 237-244.

Kertesz, A. 1999. Language and the Frontal Lobes. The Frontal Lobes. B.L. Miller, and J.L. Cummings. New York: Guilford Press. 261-276.

Kertesz, A., W. Davidson, and D.G. Munoz. 1999. Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: The Pick complex. Dementia and Geriatric Cognitive Disorders 10: 46-49.

Kertesz, A., and R. Mohs. 1999. Cognition. The Clinical Diagnosis and Management of Alzheimer's Disease. 2nd ed. S. Gauthier. London: Martin Dunitz Ltd. 179-196.

Neary, D., J.S. Snowden, L. Gustafson, U. Passant, D. Stuss, S. Black, M. Freedman, A. Kertesz, P.H. Robert, M. Albert, K. Boone, B.L. Miller, J. Cummings, and D.F. Benson. 1998. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51 (Dec.): 1546-1554.

Orange, J.B., and A. Kertesz. 1998. Efficacy of language therapy for aphasia. Physical Medicine and Rehabiliation: State of the Art Reviews, Stroke Rehabilitation 12: 501-517.

 

KNOBLER, R.L.

Rice, G.P.A., G.C. Ebers, F.D. Lublin, and R.L. Knobler. 1999. Ibuprofen treatment versus gradual introduction of interferon ß-1b in patients with MS. Neurology 52 (June): 1893-1895.

 

KOOPMAN, W.J.

Cottrell D.A., M. Kremenchutzky, G.P.A. Rice, W.J. Koopman, W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122 (April): 625-639.

 

KREMENCHUTZKY, M.

Cottrell, D.A., M. Kremenchutzky, Rice G.P.A., W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122 (April): 641-647.

Cottrell D.A., M. Kremenchutzky, G.P.A. Rice, W.J. Koopman, W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122 (April): 625-639.

 

LASSMANN, H.

Compston, D.A.S., G.C. Ebers, H. Lassmann, I. McDonald, B. Matthews, and H. Wekerle. 1998. McAlpine's Multiple Sclerosis. 3rd ed. London, England: Churchill Livingston, Division of Harcourt Brace. xiii, 592 pp. Includes bibliographical references and index.

 

LEE, D.H.

Noseworthy, J.H., P. O'Brien, B.J. Erickson, D.H. Lee, D. Sneve, G.C. Ebers, G.P.A. Rice, A. Auty, W. Hader, A. Kirk, P. Duquette, J. Carter, G. Francis, L. Metz, and E. Shuster. 1998. The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis. Neurology 51: 1342-1352.

Wiebe, S., D.G. Munoz, S. Smith, and D.H. Lee. 1999. Meningioangiomatosis: A comprehensive review of clinical and laboratory features. Brain 122: 709-726.

 

LOWNIE, S.P.

Elisevich, K., A. Ratkewicz, and S.P. Lownie. 1999. Radiosurgery of deep arteriovenous malformations of the brain. Neurosurgery Quarterly 9 (1): 33-48.

Parlea, L., R. Fahrig, D.W. Holdsworth, and S.P. Lownie. 1999. An analysis of the geometry of saccular intracranial aneurysms. American Journal of Neuroradiology 20: 1079-1089.

 

LUBLIN, F.D.

Rice, G.P.A., G.C. Ebers, F.D. Lublin, and R.L. Knobler. 1999. Ibuprofen treatment versus gradual introduction of interferon ß-1b in patients with MS. Neurology 52 (June): 1893-1895.

 

MATTHEWS, B.

Compston, D.A.S., G.C. Ebers, H. Lassmann, I. McDonald, B. Matthews, and H. Wekerle. 1998. McAlpine's Multiple Sclerosis. 3rd ed. London, England: Churchill Livingston, Division of Harcourt Brace. xiii, 592 pp. Includes bibliographical references and index.

 

MCDONALD, I.

Compston, D.A.S., G.C. Ebers, H. Lassmann, I. McDonald, B. Matthews, and H. Wekerle. 1998. McAlpine's Multiple Sclerosis. 3rd ed. London, England: Churchill Livingston, Division of Harcourt Brace. xiii, 592 pp. Includes bibliographical references and index.

 

MCLACHLAN, R.S.

Herrick, I.A., R.A. Craen, A.W. Gelb, R.S. McLachlan, J.P. Girvin, A.G. Parrent, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: electrocorticographic and epileptogenic effects. Anesthesia and Analgesia 84: 1280-1284.

McLachlan, R.S., and G.B. Young. 1999. Minimal standards for digital/quantitative electroencephalography in Canada. Canadian Journal of Neurological Sciences 26: 153.

Young, G.B., J.H. Kreeft, R.S. McLachlan, and J.D. Demelo. 1999. EEG and clinical associations with mortality in a general intensive care unit. Journal of Clinical Neurophysiology 16: 354-360.

 

MERSKEY, H.

Merskey, H., and D.E. Moulin. 1999. Handbook of Chronic Pain Syndromes. Biopsychosocial Perspectives. A. Block, E. Kremer, and E. Fernandez. New Jersey: Lawrence Erlbaum Associates, Inc. 149-163.

 

MOULIN, D.E.

Jovey, R.D., J. Ennis, J. Gardner-Nix, B. Goldman, H. Hays, M. Lynch, and D.E. Moulin. 1999. Use of opioid analgesics for the treatment of chronic noncancer pain - Consenses Statement and Guidelines from the Canadian Pain Society. Pain Research and Management 3: 197-208.

Merskey, H., and D.E. Moulin. 1999. Handbook of Chronic Pain Syndromes. Biopsychosocial Perspectives. A. Block, E. Kremer, and E. Fernandez. New Jersey: Lawrence Erlbaum Associates, Inc. 149-163.

Moulin, D.E. 1999. Opioids in chronic nonmalignant pain. Opioids in Pain Control - Basic and Clinical Aspects. C. Stein. Stanford, CA: Cambridge University Press. 295-308.

Schulz, V., D. Ward, and D.E. Moulin. 1998. Segmental hyperhidrosis as a manifestation of spinal and paraspinal disease. Canadian Journal of Neurological Sciences 25: 325-327.

 

MUNOZ, D.G.

Kertesz, A., W. Davidson, and D.G. Munoz. 1999. Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: The Pick complex. Dementia and Geriatric Cognitive Disorders 10: 46-49.

Wiebe, S., D.G. Munoz, S. Smith, and D.H. Lee. 1999. Meningioangiomatosis: A comprehensive review of clinical and laboratory features. Brain 122: 709-726.

 

NICOLLE, M.W.

Hawke, S., H. Matsuo, M.W. Nicolle, P. Wordsworth, L. Corlett, E. Spack, S. Deshpande, P.C. Driscoll, and N. Willcox. 1999. Cross-restriction of a T cell clone to HLA-DR alleles associated with rheumatoid arthritis. Arthritis & Rheumatism 42 (5): 1040-1050.

Matsuo, H., L. Corlett, S. Hawke, M.W. Nicolle, P. Driscoll, S. Deshpande, E. Spack, and N. Willcox. 1999. Distant interactions between dimorphisms in HLA-DR4 radically affect recognition of defined peptides by a specific T cell clone. International Immunology 11 (5): 835-843.

Nicolle, M.W., and G.B. Young. 1999. The neurological system. 7.1 Normal physiology (Chapter 7). Oxford Textbook of Critical Care. A.R. Webb, M.J. Shapiro, M. Singer, and P.M. Shuter. Oxford: Oxford University Press. 433-437.

 

PARRENT, A.G.

Herrick, I.A., R.A. Craen, A.W. Gelb, R.S. McLachlan, J.P. Girvin, A.G. Parrent, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: electrocorticographic and epileptogenic effects. Anesthesia and Analgesia 84: 1280-1284.

Herrick, I.A., R.A. Craen, A.W. Gelb, L.A. Miller, C.S. Kubu, J.P. Girvin, A.G. Parrent, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: patient-controlled adminstration versus neurolept analgesia. Anesthesia and Analgesia 84: 1285-1291.

Parrent, A.G. 1998. Neurosurgical treatment for pain: spinal cord stimulation (Chapter 28). Outcomes in Neurological and Neurosurgical Disorders. M. Swash. Cambridge, U.K.: Cambridge University Press. 533-546.

Parrent, A.G. 1998. Overview of the Surgical Treatment of Movement Disorders. Textbook of Stereotactic and Functional Neurosurgery. P.L. Gildenberg, and R.R. Tasker. New York: McGraw-Hill. 995-1004.

Parrent, A.G., and W.T. Blume. 1999. Stereotactic amygdalohippocampotomy for the treatment of mesial temporal lobe epilepsy. Epilepsia 40 (10): 1408-1416.

 

RICE, G.P.A.

Cottrell, D.A., M. Kremenchutzky, Rice G.P.A., W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122 (April): 641-647.

Cottrell D.A., M. Kremenchutzky, G.P.A. Rice, W.J. Koopman, W. Hader, J. Baskerville, and G.C. Ebers. 1999. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122 (April): 625-639.

Ebers, G.C., G.P.A. Rice, and The PRISMS Study Group. 1998. Randomised, double-blind, placebo-controlled study of interferon ß-1a in relapsing-remitting multiple sclerosis. Lancet 352 (9139): 1498-1504.

Noseworthy, J.H., P. O'Brien, B.J. Erickson, D.H. Lee, D. Sneve, G.C. Ebers, G.P.A. Rice, A. Auty, W. Hader, A. Kirk, P. Duquette, J. Carter, G. Francis, L. Metz, and E. Shuster. 1998. The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis. Neurology 51: 1342-1352.

Rice, G.P.A., C. Anderson, N.J. Risch, and G.C. Ebers. 1999. Male Homosexuality: Absence of linkage to microsatellite markers at Xq28. Science 284 (April): 665-667.

Rice, G.P.A., and G.C. Ebers. 1998. Interferons in the treatment of multiple sclerosis: do they prevent the progression of the disease? Archives of Neurology 55 (Dec.): 1578-1580.

Rice, G.P.A., G.C. Ebers, F.D. Lublin, and R.L. Knobler. 1999. Ibuprofen treatment versus gradual introduction of interferon ß-1b in patients with MS. Neurology 52 (June): 1893-1895.

Rice, G.P.A., B. Paszner, J. Oger, J. Lesaux, D. Paty, and G.C. Ebers. 1999. The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon ß-1b. Neurology 52 (6): 1277-1279.

 

RISCH, N.J.

Rice, G.P.A., C. Anderson, N.J. Risch, and G.C. Ebers. 1999. Male Homosexuality: Absence of linkage to microsatellite markers at Xq28. Science 284 (April): 665-667.

Sadovnick, A.D., N.J. Risch, G.C. Ebers, and The Canadian Collaborative Study Group. 1998. Canadian Collaborative Project on Genetic Susceptibility of MS - Phase 2: Rationale and method. Canadian Journal of Neurological Sciences 25 (August): 216-221.

 

RODRIGUEZ, M.

Goodin, D.S., G.C. Ebers, K.P. Johnson, M. Rodriguez, W.A. Sibley, and J.S. Wolinsky. 1999. The relationship of MS to physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52 (June): 1737-1745.

 

SADOVNICK, A.D.

Sadovnick, A.D., N.J. Risch, G.C. Ebers, and The Canadian Collaborative Study Group. 1998. Canadian Collaborative Project on Genetic Susceptibility of MS - Phase 2: Rationale and method. Canadian Journal of Neurological Sciences 25 (August): 216-221.

 

SIBLEY, W.A.

Goodin, D.S., G.C. Ebers, K.P. Johnson, M. Rodriguez, W.A. Sibley, and J.S. Wolinsky. 1999. The relationship of MS to physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52 (June): 1737-1745.

 

SPENCE, J.D.

Badner, N.H., K. Drader, D. Freeman, and J.D. Spence. 1998. The use of intraoperative nitrous oxide leads to postoperative increases in plasma homocysteine. Anesthesia and Analgesia 87: 711-713.

Campbell, R.C., E. Burgess, G. Taylor, E. Wilson, J. Cleroux, J.G. Fodor, L. Leiter, and J.D. Spence. 1999. Lifestyle changes to prevent and control hypertension: Do they work? A summary of the Canadian concensus conference. Canadian Medical Association Journal 160 (9): 1341-1343.

Miller, D.B., and J.D. Spence. 1998. Clinical pharmacokinetics of fibric acid derivatives (fibrates). Clinical Pharmacokinetics 34 (2): 155-162.

Spence, J.D. (1999). Clinical pharmacokinetics of fibric acid derivatives (Fibrates). Clinical Pharmacokinetics 34 (2): 155.

Spence, J.D. 1998. Metabolism of fibric acid derivatives. Clinical Pharmacokinetics 34 (5): 419-420.

Spence, J.D., P.A. Barnett, D.E. Bulman, and R.A. Hegele. 1999. An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis. Atherosclerosis 144: 129-134.

 

TAMAYO, A.

Tamayo, A., and V.C. Hachinski. 1999. Acute Intervention in Stroke. Third European American Conference of Neurology. A.A. Gimeno, and P. Herman. Madrid: Fundacion Ramon Areces. 183-205.

 

WEKERLE, H.

Compston, D.A.S., G.C. Ebers, H. Lassmann, I. McDonald, B. Matthews, and H. Wekerle. 1998. McAlpine's Multiple Sclerosis. 3rd ed. London, England: Churchill Livingston, Division of Harcourt Brace. xiii, 592 pp. Includes bibliographical references and index.

 

WIEBE, S.

Blume, W.T., and S. Wiebe. 1999. Occipital Lobe Epilepsies. Advances in Neurology. P.D. Williamson, A.M. Siegel, D.W. Roberts, W.M. Thadani, and M.S. Gazzaniga. Philadelphia: Lippincott-Raven.

Gross, D.W., S. Wiebe, and W.T. Blume. 1999. The periodicity of lateralized epileptiform discharges. Clinical Neurophysiology 110: 1516-1520.

Teasell, R.W., M.P. McRae, and S. Wiebe. 1999. Post Stroke Seizures in Stroke Rehabilitation Patients. Journal of Stroke and Cerebrovascular Diseases 8 (2): 1-5.

Wiebe, S., D.R. Bellhouse, C. Fallahay, and M. Eliasziw. 1999. Burden of Epilepsy: The Ontario Health Survey. Canadian Journal of Neurological Sciences .

Wiebe, S., and J. Butler. 1998. Longterm Complications in Stroke. Physical Medicine and Rehabilitation: State of the Art Reviews 12 (3).

Wiebe, S., D.G. Munoz, S. Smith, and D.H. Lee. 1999. Meningioangiomatosis: A comprehensive review of clinical and laboratory features. Brain 122: 709-726.

 

WOLINSKY, J.S.

Goodin, D.S., G.C. Ebers, K.P. Johnson, M. Rodriguez, W.A. Sibley, and J.S. Wolinsky. 1999. The relationship of MS to physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52 (June): 1737-1745.

 

YOUNG, G.B.

da Silva, O., D. Alexandrou, D. Knoppert, and G.B. Young. 1999. Seizure and electrographic changes in the newborn period induced by opiates and corrected by naloxone infusion. Journal of Perinatology 19: 120-123.

da Silva, O., G.M. Collado Guzman, and G.B. Young. 1998. The value of standard electroencephalograms in the evaluation of the newborn recurrent apneas. Journal of Perinatology 18: 377-380.

McLachlan, R.S., and G.B. Young. 1999. Minimal standards for digital/quantitative electroencephalography in Canada. Canadian Journal of Neurological Sciences 26: 153.

Nicolle, M.W., and G.B. Young. 1999. The neurological system. 7.1 Normal physiology (Chapter 7). Oxford Textbook of Critical Care. A.R. Webb, M.J. Shapiro, M. Singer, and P.M. Shuter. Oxford: Oxford University Press. 433-437.

Sundaram, M., R.M. Sadler, G.B. Young, and N. Pillay. 1999. EEG in epilepsy: current perspectives. Canadian Journal of Neurological Sciences 26: 255-262.

Young, G.B. 1998. Metabolic and inflammatory cerebral diseases: electrophysiological aspects. Canadian Journal of Neurological Sciences 25 (S): S16-S20.

Young, G.B., and C.F. Bolton. 1999. Good Fare Lessens Care (Editorial). Critical Care Medicine 27: 11.

Young, G.B., and V.C. Campbell. 1999. EEG monitoring in the intensive care unit: Pitfalls and caveats. Journal of Clinical Neurophysiology 16: 40-45.

Young, G.B., and K.G. Jordan. 1998. Do nonconvulsive seizures damage the brain? - Yes. Archives of Neurology 55: 117-119.

Young, G.B., J.H. Kreeft, R.S. McLachlan, and J.D. Demelo. 1999. EEG and clinical associations with mortality in a general intensive care unit. Journal of Clinical Neurophysiology 16: 354-360.

Young, G.B., and S.E. Pigott. 1999. The neurobiological basis of consciousness. Archives of Neurology 56: 153-157.

Young, G.B., J. Teitelbaum, S. Seshia, and M.-A. Beaulieu. 1999. Guidelines for the Diagnosis of Brain Death. Canadian Journal of Neurological Sciences 26: 64-66.